S-1 · resale registration
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: ILExchange: Nasdaq
DilutionScan read 35 of NeuroSense Therapeutics Ltd.'s SEC filings and found 7 warrant series, 2 ATM programs, 1 equity line, 5 shelf registrations, 1 S-1 registration and 2 completed offerings on file for NRSN. The latest dilution event on file is ATM sales on Jul 31, 2026. Analysis updated Oct 1, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 + active equity line · latest dilution event 95 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jul 31, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Issued 2021
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2023
Total capacity
Sold to date
Issued 2024
Commitment
Sold to date
Issued 2023
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2025
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z